Altered distribution and expression pattern of e-cadherin in hepatocellular carcinomas: Correlations with prognosis and clinical features

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6455-6461

  Jiang, Xue Mei ^a   Zhang, Ju Bo ^a   Xiong, Ju ^b   Huang, Xiao Xi ^c   Ren, Zheng Gang ^a  

^a FUDAN UNIVERSITY   (China)

^b Xinjiang Uygur Autonomous Region Hospital   (China)

^c HAIKOU PEOPLE S HOSPITAL   (China)

Author keywords

E cadherin; Hepatocellular carcinoma; Tumor suppressor

Indexed keywords

CADHERIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CELL MEMBRANE; CYTOPLASM; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TUMOR; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CADHERINS; CARCINOMA, HEPATOCELLULAR; CELL MEMBRANE; CYTOPLASM; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84877046275     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6455     Document Type: Article

References (31)

1. Arulanandam R, Vultur A, Cao J, et al (2009). Cadherin-cadherin engagement promotes cell survival via Rac1/Cdc42 and signal transducer and activator of transcription-3. Mol Cancer Res, 7, 1310-27.
2. Brunt EM (2000). Grading and staging the histopathological lesions of chronic hepatitis: the Knodell histology activity index and beyond. Hepatology, 31, 241-6.
3. Bussemakers MJ, van Bokhoven A, Mees SG, Kemler R, Schalken JA (1993). Molecular cloning and characterization of the human E-cadherin cDNA. Mol Biol Rep, 17, 123-8.
4. Cespedes MV, Larriba MJ, Pavon MA, et al (2010). Site-dependent E-cadherin cleavage and nuclear translocation in a metastatic colorectal cancer model. Am J Pathol 177: 2067-2079.
5. Comoglio PM, Boccaccio C, Trusolino L (2003). Interactions between growth factor receptors and adhesion molecules: breaking the rules. Curr Opin Cell Biol, 15, 565-71.
6. Cowin P, Rowlands TM, Hatsell SJ (2005). Cadherins and catenins in breast cancer. Curr Opin Cell Biol, 17, 499-508.
7. Du GS, Wang JM, Lu JX, et al (2009). Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma. Ann Surg Oncol, 16, 1578-86.
8. Fransvea E, Angelotti U, Antonaci S, Giannelli G (2008). Blocking transforming growth factor-beta up-regulates E-cadherin and reduces migration and invasion of hepatocellular carcinoma cells. Hepatology, 47, 1557-66.
9. Garcia S, Martini F, De Micco C, et al (1998). [Prognostic value of E-cadherin expression in hepatocellular carcinoma]. Ann Pathol, 18, 98-102.
10. Han AC, Peralta-Soler A, Knudsen KA, et al (1997). Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues. Hum Pathol, 28, 641-5.
11. Ikeda K, Arase Y, Kobayashi M, et al (2003). Significance of multicentric cancer recurrence after potentially curative ablation of hepatocellular carcinoma: a longterm cohort study of 892 patients with viral cirrhosis. J Gastroenterol, 38, 865-76.
12. Jiang WG, Mansel RE (2000). E-cadherin complex and its abnormalities in human breast cancer. Surg Oncol, 9, 151-71.
13. Kavgaci H, Yildiz B, Fidan E, et al (2010). The effects of E-cadherin and bcl-2 on prognosis in patients with breast cancer. Bratisl Lek Listy, 111, 493-7.
14. Kensler TW, Qian GS, Chen JG, Groopman JD (2003). Translational strategies for cancer prevention in liver. Nat Rev Cancer, 3, 321-9.
15. Lewis-Tuffin LJ, Rodriguez F, Giannini C, et al (2010). Misregulated E-cadherin expression associated with an aggressive brain tumor phenotype. PLoS One, 5, e13665.
16. Mayer B, Johnson JP, Leitl F, et al (1993). E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res, 53, 1690-5.
17. Montserrat N, Gallardo A, Escuin D, et al (2011). Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort?. Hum Pathol, 42, 103-10.
18. Mosesson Y, Mills GB, Yarden Y (2008). Derailed endocytosis: an emerging feature of cancer. Nat Rev Cancer, 8, 835-50.
19. Poon RT, Fan ST, Ng IO, et al (2000). Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer, 89, 500-7.
20. Qian YB, Zhang JB, Wu WZ, et al (2006). P48 is a predictive marker for outcome of postoperative interferon-alpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer, 107, 1562-9.
21. Regimbeau JM, Abdalla EK, Vauthey JN, et al (2004). Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol, 85, 36-41.
22. Ross JS, del Rosario AD, Figge HL, et al (1995). E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder. Hum Pathol, 26, 940-4.
23. Shim HS, Yoon BS, Cho NH (2009). Prognostic significance of paired epithelial cell adhesion molecule and E-cadherin in ovarian serous carcinoma. Hum Pathol, 40, 693-8.
24. Shirabe K, Kanematsu T, Matsumata T, et al (1991). Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology, 14, 802-5.
25. Sobin LH (2002). TNM classification of malignant tumors, 6th edn. Geneva, Switzerland: International Union Against Cancer.
26. Tang ZY, Ye SL, Liu YK, et al (2004). A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol, 130, 187-96.
27. Thiery JP (2002). Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer, 2, 442-54.
28. Wei Y, Van Nhieu JT, Prigent S, et al (2002). Altered expression of E-cadherin in hepatocellular carcinoma: correlations with genetic alterations, beta-catenin expression, and clinical features. Hepatology, 36, 692-701.
29. Wijnhoven BP, Pignatelli M (1999) E-cadherin-catenin: more than a "sticky" molecular complex. Lancet, 354, 356-7.
30. Wong AS, Gumbiner BM (2003). Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin. J Cell Biol, 161, 1191-203.
31. Xu HX, Zhu XD, Zhuang PY, et al (2011). Expression and prognostic significance of placental growth factor in hepatocellular carcinoma and peritumoral liver tissue. Int J Cancer, 128, 1559-69